Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain
Public ClinicalTrials.gov record NCT00108771. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Double-Blind, Parallel, Randomized, Placebo-Controlled 12-Week Efficacy and Safety Assessment of ZR-02-01 in the Treatment of Chronic, Moderate to Severe Osteoarthritis (OA) Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effectiveness of the Matrix Fentanyl Patch ZR-02-01 in providing pain relief.
Study identification
- NCT ID
- NCT00108771
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 202 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2004
- Primary completion
- Aug 31, 2006
- Completion
- Aug 31, 2006
- Last update posted
- Jun 4, 2012
2004 – 2006
United States locations
- U.S. sites
- 13
- U.S. states
- 6
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Reserach Center | Phoenix | Arizona | 85023 | — |
| Redpoint Research | Phoenix | Arizona | 85029 | — |
| Sharp Rees-Stealy Medical Group | San Diego | California | 92101 | — |
| San Diego Arthritis Medical Clinic | San Diego | California | 92108 | — |
| Boling Clinical Trials | Upland | California | 91786 | — |
| Radiant Research | Daytona Beach | Florida | 32114 | — |
| Ocala Rheumatology | Ocala | Florida | 34474 | — |
| Tampa Medical Group | Tampa | Florida | 33614 | — |
| New Orleans Center for Clinical Research | New Orleans | Louisiana | 70119 | — |
| Pain Trials Center - Brigham & Women's Hospital | Boston | Massachusetts | 02115 | — |
| Phase III Clinical Trials | Fall River | Massachusetts | 02720 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| Analgesic Development Ltd. | New York | New York | 10022 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00108771, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2012 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00108771 live on ClinicalTrials.gov.